Literature DB >> 22707411

CGG trinucleotide repeat length modulates neural plasticity and spatiotemporal processing in a mouse model of the fragile X premutation.

Michael R Hunsaker1, Kyoungmi Kim, Rob Willemsen, Robert F Berman.   

Abstract

The fragile X premutation is a CGG repeat expansion on the FMR1 gene between 55 and 200 repeats in length. It has been proposed that impaired spatiotemporal function underlies cognitive deficits in genetic disorders, including the fragile X premutation. This study characterized the role of the premutation for cognitive function by demonstrating CGG KI mice with 70-198 CGG repeats show deficits across tasks requiring spatial and temporal pattern separation. To elucidate mechanisms whereby CGG repeats affect spatiotemporal processing, hippocampal slices were evaluated for LTP, LTD, and mGluR1/5 LTD. Increasing CGG repeat length modulated the induction of LTP, LTD, and mGluR1/5 LTD, as well as behavioral tasks emphasizing spatiotemporal processing. Despite the deficits in the induction of all forms of plasticity, there were no differences in expression of plasticity once evoked. These data provide evidence for a neurocognitive endophenotype in the CGG KI mouse model of the premutation in which CGG repeat length negatively modulates plasticity and spatiotemporal attention.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22707411      PMCID: PMC3449027          DOI: 10.1002/hipo.22043

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  49 in total

Review 1.  A behavioral analysis of dentate gyrus function.

Authors:  Raymond P Kesner
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

2.  Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation.

Authors:  Robert F Berman; Karl D Murray; Gloria Arque; Michael R Hunsaker; H Jürgen Wenzel
Journal:  Epilepsia       Date:  2012-06       Impact factor: 5.864

Review 3.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

Review 4.  Clues to the foundations of numerical cognitive impairments: evidence from genetic disorders.

Authors:  Tony J Simon
Journal:  Dev Neuropsychol       Date:  2011       Impact factor: 2.253

5.  Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation.

Authors:  David Hessl; John M Wang; Andrea Schneider; Kami Koldewyn; Lien Le; Christine Iwahashi; Katherine Cheung; Flora Tassone; Paul J Hagerman; Susan M Rivera
Journal:  Biol Psychiatry       Date:  2011-07-23       Impact factor: 13.382

6.  Reduced Hippocampal Activation During Recall is Associated with Elevated FMR1 mRNA and Psychiatric Symptoms in Men with the Fragile X Premutation.

Authors:  Kami Koldewyn; David Hessl; John Adams; Flora Tassone; Paul J Hagerman; Randi J Hagerman; Susan M Rivera
Journal:  Brain Imaging Behav       Date:  2008-01-18       Impact factor: 3.978

7.  Lifespan changes in working memory in fragile X premutation males.

Authors:  Kim M Cornish; Cary S Kogan; Lexin Li; Jeremy Turk; Sebastien Jacquemont; Randi J Hagerman
Journal:  Brain Cogn       Date:  2008-12-27       Impact factor: 2.310

8.  Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model.

Authors:  Ali Entezam; Rea Biacsi; Bonnie Orrison; Tapas Saha; Gloria E Hoffman; Ed Grabczyk; Robert L Nussbaum; Karen Usdin
Journal:  Gene       Date:  2007-03-16       Impact factor: 3.688

9.  Imbalanced pattern completion vs. separation in cognitive disease: network simulations of synaptic pathologies predict a personalized therapeutics strategy.

Authors:  Jesse E Hanson; Daniel V Madison
Journal:  BMC Neurosci       Date:  2010-08-13       Impact factor: 3.288

Review 10.  Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature.

Authors:  Jessica Ezzell Hunter; Ann Abramowitz; Michele Rusin; Stephanie L Sherman
Journal:  Genet Med       Date:  2009-02       Impact factor: 8.822

View more
  20 in total

Review 1.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

Review 2.  What has been learned from mouse models of the Fragile X Premutation and Fragile X-associated tremor/ataxia syndrome?

Authors:  Molly M Foote; Milo Careaga; Robert F Berman
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

3.  Adaptation of the Arizona Cognitive Task Battery for use with the Ts65Dn mouse model (Mus musculus) of Down syndrome.

Authors:  Michael R Hunsaker; Genevieve K Smith; Raymond P Kesner
Journal:  J Comp Psychol       Date:  2017-03-23       Impact factor: 2.231

4.  Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of fragile X-associated tremor/ataxia syndrome.

Authors:  Gaëlle Robin; José R López; Glenda M Espinal; Susan Hulsizer; Paul J Hagerman; Isaac N Pessah
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

5.  ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI.

Authors:  Jin-Chen Yang; Lillian Chi; Sara Teichholtz; Andrea Schneider; Rawi Nanakul; Ralph Nowacki; Andreea Seritan; Bruce Reed; Charles DeCarli; Vicente J Iragui; Marta Kutas; Paul J Hagerman; Randi J Hagerman; John M Olichney
Journal:  Neuropsychologia       Date:  2014-08-09       Impact factor: 3.139

6.  Altered neural activity in the 'when' pathway during temporal processing in fragile X premutation carriers.

Authors:  So-Yeon Kim; Flora Tassone; Tony J Simon; Susan M Rivera
Journal:  Behav Brain Res       Date:  2014-01-05       Impact factor: 3.332

7.  Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.

Authors:  Aimee V Franklin; Margaret K King; Valle Palomo; Ana Martinez; Lori L McMahon; Richard S Jope
Journal:  Biol Psychiatry       Date:  2013-09-13       Impact factor: 13.382

8.  Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.

Authors:  Adam J Iliff; Abigail J Renoux; Amy Krans; Karen Usdin; Michael A Sutton; Peter K Todd
Journal:  Hum Mol Genet       Date:  2012-12-18       Impact factor: 6.150

9.  Reduced activity-dependent protein levels in a mouse model of the fragile X premutation.

Authors:  Ramona E von Leden; Lindsey C Curley; Gian D Greenberg; Michael R Hunsaker; Rob Willemsen; Robert F Berman
Journal:  Neurobiol Learn Mem       Date:  2014-01-23       Impact factor: 2.877

10.  Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study.

Authors:  Jin-Chen Yang; Yu-Qiong Niu; Christa Simon; Andreea L Seritan; Lawrence Chen; Andrea Schneider; Shayan T Moghaddam; Paul J Hagerman; Randi J Hagerman; John M Olichney
Journal:  Neuropsychopharmacology       Date:  2014-05-29       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.